Tka denied as not FDA-approved for this use by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for tka are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied Your Total Knee Arthroplasty as Not FDA-Approved

A not-FDA-approved denial for total knee arthroplasty (TKA) most commonly applies to a specific implant component, material, surface coating, or surgical technology — not to knee replacement surgery itself, which has well-established FDA clearance pathways. UnitedHealthcare may issue this denial when the proposed implant system has received 510(k) clearance under a different intended use, when a newer implant material or component has not completed its clearance review, or when a surgical device (such as a patient-specific cutting guide or robotic system accessory) lacks the specific clearance UHC requires.

This denial is often resolvable because the implant manufacturer can provide FDA clearance documentation, or because the specific component in question is covered under a broader cleared device family.

## Your Federal Appeal Rights

Under ACA Section 2719, most commercial plans must offer a full internal appeal and independent external review for adverse coverage decisions, including FDA-approval-based denials. Under ERISA Section 503, self-funded members are entitled to a written, reasoned denial and a full-and-fair review. External review is generally available within four months of a final internal denial. If surgical delay creates medical risk, request expedited review for a 72-hour turnaround.

## The Appeal Process

1. Identify the specific component or device UHC flagged — the denial must specify what is not FDA-approved. 2. Obtain FDA clearance documentation from the implant manufacturer for the flagged item. 3. File an internal appeal with the clearance documentation and your surgeon's explanation. 4. Request external review if the internal appeal is upheld.

## Documentation to Gather

• FDA clearance records: 510(k) clearance letters, PMA approval documentation, or manufacturer compliance letters for the specific implant or device component.
• Surgeon clarification letter: Explaining the exact device being used, its regulatory status, and how it fits within cleared device families.
• Diagnosis and surgical plan: Imaging, examination findings, and operative plan documenting why TKA is indicated.
• Prior conservative treatment history: Dated records showing non-surgical options have been appropriately exhausted.

## Criteria-Mapping Structure

Obtain UHC's medical policy for TKA and its language on FDA-approval requirements. Map each requirement:

| Policy FDA-Approval Requirement | Supporting Documentation | |---|---| | Procedure-level FDA status | Implant system FDA clearance letter | | Component-level clearance | Manufacturer 510(k) or PMA documentation | | Intended-use match | Surgeon letter confirming on-label use |

Appeals on FDA-approval grounds succeed most efficiently when the implant manufacturer's regulatory affairs team provides clearance documentation directly to UHC. Ask your surgeon's office to request this documentation as part of the appeal package — it typically resolves the denial without requiring an external review.